Prometheus MedTech.AI has been named one of the Top 40 most promising startups in the prestigious K-Startup Grand Challenge 2025 (KSGC) — Korea’s leading international startup acceleration program.
From 2,626 applications representing 169 countries, only 40 companies were selected to advance. This recognition highlights not only the global potential of our technology, but also our exceptional commercialization strategy for bringing AI-driven cardiac screening to healthcare systems worldwide.
KSGC is one of the world’s most competitive and respected startup competitions, positioning Korea as a global hub for innovation. For Prometheus, being chosen among the Top 40 confirms the urgency and relevance of our mission:
As part of this stage, we will participate in The Global Startup in Jeju (September 1–5, 2025), held in parallel with the APEC Global Startup Side Event and the Small and Medium Enterprises Ministerial Meeting (SMEMM). This unique platform will:
This opportunity not only validates our innovation but also accelerates our mission of bringing Ultra Echo Scan (UES)— the world’s first AI-based screening test for early CHD detection — into clinical practice across Asia and beyond.
Our CEO APAC, Piotr Ściegienka, will represent Prometheus MedTech.AI in Korea, engaging with local stakeholders to drive market entry and integration of our technology into the healthcare system.
This is a major step forward on our journey — and we’re just getting started. Stay tuned on LinkedIn as we continue to shape the future of neonatal care with AI.
Over the past months, several media outlets have covered the development of Prometheus MedTech.AI and our mission to improve early…
Prometheus MedTech.AI has received the Wektory 2025 award in the Start-up 2025 category, granted by Employers of Poland (Pracodawcy RP) — one of…
How can technology support health? At Prometheus MedTech.AI, we believe in empowering clinicians with smarter tools — technology that enhances…
Prometheus MedTech.AI received the Main Award at the Deeptech Accelerator DemoDay held during the Podkarpackie Science and Innovation Festival in…
At ECAI 2025 in Bologna — Europe’s leading conference dedicated to artificial intelligence — we presented PrAViC, a probabilistic framework…
We’re proud to share that Prometheus MedTech.AI has received the “Visionary of the Polish Economy” Award named after Marek Goliszewski, presented…
We’re proud to be ranked among the Top 3 AI startups in healthcare globally and the Top 15 medical startups overall…
Prometheus MedTech.AI has been named one of the Top 40 most promising startups in the prestigious K-Startup Grand Challenge 2025 (KSGC) —…
Prometheus MedTech.AI has taken a major step toward its U.S. market entry and future FDA certification by participating in NeoHeart 2025…
We’re proud to announce that our innovative solution, Ultra Echo Scan (UES), has been selected among the Top 80 startups worldwide for the…
We are pleased to announce that the Prometheus MedTech.AI team has recently completed a productive visit to New York City, marking…
From the Top 10 Health Startups in Europe to the stage in Madrid — our team joined one of the world’s most prestigious innovation summits to connect, pitch, and share our mission.